《大行報告》中金首予朝聚眼科(02219.HK)「跑贏行業」評級 目標價7.68元
中金發表評級報告指,與大部分同業相比,朝聚眼科(02219.HK)在興建醫院所需時間較少,更快達到收支平衡。該行認為,這顯示出集團在集群化、集中化、標準化營運體系的優勢,並預料公司可透過自然方式和併購達到持續增長。該行預測公司去年每股盈達0.24元人民幣、今年則達0.29元人民幣、以及明年達0.36元人民幣,意味著複合年均增長率達22.8%;中金首予其目標價為7.68元,投資評級為「跑贏行業」。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.